查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908494

导管导引线市场规模、份额和趋势分析报告：按产品、地区和细分市场预测（2026-2033 年）

Guidewires Market Size, Share & Trends Analysis Report By Product (Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, Neurovascular Guidewires), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

导管导引线市场概览

预计到 2025 年，全球导管导引线市场规模将达到 28.8 亿美元，到 2033 年将达到 44.3 亿美元。

预计从 2026 年到 2033 年，导丝市场将以 5.53% 的复合年增长率成长。导管导引线市场的成长受以下因素驱动：微创和导管介入手术数量的增加、心血管和周边血管疾病盛行率的上升、导管导引线设计和材料的不断进步以提高柔软性和扭矩控制，以及全球医院和门诊手术中心介入手术的日益普及。

全球心血管疾病负担日益加重，包括冠状动脉疾病、周边动脉疾病和结构性心臟疾病，这是导管导引线市场成长要素之一。随着人口老化、久坐不动的生活方式、肥胖、糖尿病和高血压等因素导致心血管疾病（CVD）发病率上升，医院进行的诊断和介入手术数量不断增加，例如血管成形术、支架置入术术、导管介入成像和微创血管修復术。导管导引线在这些手术中至关重要，它能够引导导丝穿过复杂的血管、跨越阻塞部位并精准放置器械。此外，微创介入治疗因其能够缩短住院时间、减少併发症并改善患者预后而日益受到青睐，这也进一步推动了对高度专业导管导引线的需求。

此外，心绞痛是全球范围内导致发病率和死亡率的主要原因之一，影响大量患者。例如，根据美国国家医学图书馆的数据，2024年全球心绞痛盛行率约为2.0%至7.0%。此外，2023年中国报告的心绞痛病例超过280.6万例。有证据表明，心绞痛会使严重心血管事件的风险增加一倍。目前，冠状动脉疾病（CAD）每年在欧洲造成410万人死亡，其中82.0%的死亡病例发生在65岁及以上的老年族群。

技术进步是推动导管导引线应用的关键因素之一。先进的导管导引线可依特定需求进行客製化，并可进行远端控制，进而提高手术成功率，加速微创手术的普及。这些导管导引线与影像设备和手术机器人的结合，为现代外科手术的应用开闢了无限可能。例如，2024年4月，Teleflex推出了Watson临时起搏导导管导引线，专为球囊主动脉瓣环成形（BAV）和经导管主动脉瓣置换术（TAVR）而设计。此导管导引线可提供瓣膜输送辅助、双重功能以及心室双极起搏，旨在减少与传统技术相关的併发症，并提高手术效率。

此外，人口老化进一步推动了市场成长。例如，根据世界卫生组织估计，到2030年，全球六分之一的人口将达到或超过60岁。预计到2050年，这一人口数将翻倍。此外，老年族群的疾病发生率也显着高于其他族群，其中包括心血管疾病、缺血性心臟疾病、血管性失智症和多发性硬化症。

目录

第一章调查方法和范围

第二章执行摘要

第三章导管导引线市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 导管导引线市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章导管导引线市场：产品、估算与趋势分析

  • 导管导引线市场：按产品分類的差异分析
  • 导管导引线市场：产品展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 冠状动脉导线
  • 末梢血管导管导引线
  • 泌尿系统导管导引线
  • 神经血管导管导引线

第五章导管导引线市场：区域、估算与趋势分析

  • 区域仪錶板
  • 按地区分類的导管导引线市场波动分析
  • 导管导引线市场：按诊断和地区分類的估算和趋势分析
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争情势

  • 市场参与企业分类
  • 企业市场占有率分析，2025 年
  • 主要企业简介
    • Boston Scientific Corporation
    • Medtronic
    • Cook
    • B. Braun
    • Terumo Medical Corporation
    • Abbott
    • Stryker
    • Teleflex Incorporated
    • Codman Neuro（Integer Holdings Corporation）
    • Merit Medical Systems
    • BD
    • Olympus Corporation
    • Asahi Intecc Co., Ltd.
    • ConMed Corporation
    • Argon Medical Devices
    • SP Medical A/S
    • TE Con​​nectivity（前身为 Creganna Medical）
    • Galt Medical Corp
    • Balton
    • Manish Medi Innovation
    • ST. Stone Medical Devices Private Limited
    • Custom Wire Technologies, Inc.
    • ACE Medical Devices
    • BrosMed Medical Co., Ltd.
    • Cathwide Medical Co. Ltd.
    • Creo Medical
    • Foshan Dihua Technology Co., Ltd.
    • AngioDynamics
    • Cordis（Cardinal Health）
Product Code: 978-1-68038-243-3

Guidewires Market Summary

The global guidewires market size was valued at USD 2.88 billion in 2025 and is projected to reach USD 4.43 billion by 2033, growing at a CAGR of 5.53% from 2026 to 2033. The growth of the guidewires market is driven by the rising volume of minimally invasive and catheter-based procedures, increasing prevalence of cardiovascular and peripheral vascular diseases, continuous advancements in guidewire design and materials to improve flexibility and torque control, and expanding adoption of interventional procedures across hospitals and ambulatory surgical centers worldwide.

The rising global burden of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and structural heart disorders, is one of the significant growth drivers for the guidewires market. As the incidence of CVD increases due to ageing populations, sedentary lifestyles, obesity, diabetes, and hypertension, hospitals are witnessing a higher volume of diagnostic and interventional procedures such as angioplasty, stent placement, catheter-based imaging, and minimally invasive vascular repairs. These procedures rely heavily on guidewires for navigating complex vasculature, crossing occlusions, and enabling precise device placement. Moreover, the growing preference for minimally invasive interventions, favored for shorter hospital stays, reduced complications, and better patient outcomes, further accelerates the demand for highly specialized guidewires.

Moreover, angina pectoris, a leading cause of morbidity and mortality globally, affects a significant number of individuals. For instance, according to the National Library of Medicine, the prevalence of angina pectoris worldwide ranged from approximately 2.0% to 7.0% in 2024. In addition, in 2023, there were over 2,806,000 reported cases of angina pectoris in China. There is evidence that angina doubles the risk of serious cardiovascular events. Currently, coronary artery disease (CAD) accounts for 4.1 million deaths in Europe annually, with individuals over 65 accounting for 82.0% of these deaths.

Technological advancements are one of the key factors boosting the application of the guidewire. The advanced guidewires can be customized for specific requirements and can be operated remotely. This leads to an increased success rate of the procedures and thus the adoption rate for minimally invasive surgeries. The integration of these guidewires with imaging modalities and surgical robots has endless applications in modern surgical practices. For instance, in April 2024, Teleflex Incorporated introduced the Wattson Temporary Pacing Guidewire, designed specifically for use during Balloon Aortic Valvuloplasty (BAV) and Transcatheter Aortic Valve Replacement (TAVR). This guidewire offers supporting valve delivery, dual functionality, and ventricular bipolar pacing. It aims to improve procedural efficiencies and reduce complications associated with traditional methods.

Furthermore, rising geriatric population further fuels market growth. For instance, the WHO estimates that by 2030, 1 in 6 people worldwide will be 60 years of age or older. The same demographic will double by 2050. Moreover, diseases are far more common among older adults. These include cardiovascular disease, ischemic heart disease, vascular dementia, and multiple sclerosis, among others.

Global Guidewires Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the guidewires market report on the basis of product, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Coronary Guidewires
  • Peripheral Guidewires
  • Urology Guidewires
  • Neurovascular Guidewires
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Guidewires Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising burden of cardiovascular & peripheral diseases
      • 3.2.1.2. Growing adoption of minimally invasive procedures
      • 3.2.1.3. Technological advancements in guidewire design
      • 3.2.1.4. Expansion of Cath labs and interventional centers
      • 3.2.1.5. Increasing stroke intervention adoption
      • 3.2.1.6. Strong industry presence & distribution networks
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Alternative treatment options
      • 3.2.2.2. Stringent regulatory requirements
      • 3.2.2.3. Potential risks and complications
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. High growth in emerging markets
      • 3.2.3.2. Adoption of robot-assisted & imaging-guided interventions
      • 3.2.3.3. Increased use of premium CTO & specialty wires
      • 3.2.3.4. Product differentiation through materials & coatings
      • 3.2.3.5. Local manufacturing & OEM opportunities
      • 3.2.3.6. Rising Focus on Neurovascular Interventions
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Supply chain constraints (nitinol & specialty coatings)
      • 3.2.4.2. Growing competition & market saturation
  • 3.3. Guidewires Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Guidewires Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Guidewires Market: Product Movement Analysis
  • 4.3. Guidewires Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Coronary Guidewires
    • 4.5.1. Coronary Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Peripheral Guidewires
    • 4.6.1. Peripheral Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Urology Guidewires
    • 4.7.1. Urology Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Neurovascular Guidewires
    • 4.8.1. Neurovascular Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Guidewires Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Dashboard
  • 5.2. Regional Guidewires Market movement analysis
  • 5.3. Guidewires Market: Regional Estimates & Trend Analysis by Diagnosis
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. North America
    • 5.5.1. North America Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. U.S. Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Canada Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. Reimbursement scenario
      • 5.5.4.5. Mexico Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. UK Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Germany Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement scenario
      • 5.6.4.5. France Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement scenario
      • 5.6.5.5. Italy Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Competitive Scenario
      • 5.6.6.3. Regulatory Framework
      • 5.6.6.4. Reimbursement scenario
      • 5.6.6.5. Spain Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.7. Denmark
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Competitive Scenario
      • 5.6.7.3. Regulatory Framework
      • 5.6.7.4. Reimbursement scenario
      • 5.6.7.5. Denmark Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Competitive Scenario
      • 5.6.8.3. Regulatory Framework
      • 5.6.8.4. Reimbursement scenario
      • 5.6.8.5. Sweden Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.9. Norway
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Competitive Scenario
      • 5.6.9.3. Regulatory Framework
      • 5.6.9.4. Reimbursement scenario
      • 5.6.9.5. Norway Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Japan
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. Reimbursement scenario
      • 5.7.2.5. Japan Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.3. China
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Reimbursement scenario
      • 5.7.3.5. China Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.4. India
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. Reimbursement scenario
      • 5.7.4.5. India Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Reimbursement scenario
      • 5.7.5.5. South Korea Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.6. Australia
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory Framework
      • 5.7.6.4. Reimbursement scenario
      • 5.7.6.5. Australia Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.7. Thailand
      • 5.7.7.1. Key Country Dynamics
      • 5.7.7.2. Competitive Scenario
      • 5.7.7.3. Regulatory Framework
      • 5.7.7.4. Reimbursement scenario
      • 5.7.7.5. Thailand Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Latin America Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.2. Brazil
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory Framework
      • 5.8.2.4. Reimbursement scenario
      • 5.8.2.5. Brazil Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory Framework
      • 5.8.3.4. Reimbursement scenario
      • 5.8.3.5. Argentina Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Middle East & Africa
    • 5.9.1. Middle East & Africa Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory Framework
      • 5.9.2.4. Reimbursement scenario
      • 5.9.2.5. South Africa Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory Framework
      • 5.9.3.4. Reimbursement scenario
      • 5.9.3.5. Saudi Arabia Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Competitive Scenario
      • 5.9.4.3. Regulatory Framework
      • 5.9.4.4. Reimbursement scenario
      • 5.9.4.5. UAE Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Competitive Scenario
      • 5.9.5.3. Regulatory Framework
      • 5.9.5.4. Reimbursement scenario
      • 5.9.5.5. Kuwait Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Company Share Analysis, 2025
  • 6.3. Key Company Profiles
    • 6.3.1. Boston Scientific Corporation
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Product benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Medtronic
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Product benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Cook
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Product benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. B. Braun
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Terumo Medical Corporation
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Abbott
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Stryker
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Teleflex Incorporated
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Codman Neuro (Integer Holdings Corporation)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Merit Medical Systems
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. BD
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Olympus Corporation
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Asahi Intecc Co., Ltd.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. ConMed Corporation
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Argon Medical Devices
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. SP Medical A/S
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives
    • 6.3.17. TE Connectivity (formerly Creganna Medical)
      • 6.3.17.1. Company overview
      • 6.3.17.2. Financial performance
      • 6.3.17.3. Product benchmarking
      • 6.3.17.4. Strategic initiatives
    • 6.3.18. Galt Medical Corp
      • 6.3.18.1. Company overview
      • 6.3.18.2. Financial performance
      • 6.3.18.3. Product benchmarking
      • 6.3.18.4. Strategic initiatives
    • 6.3.19. Balton
      • 6.3.19.1. Company overview
      • 6.3.19.2. Financial performance
      • 6.3.19.3. Product benchmarking
      • 6.3.19.4. Strategic initiatives
    • 6.3.20. Manish Medi Innovation
      • 6.3.20.1. Company overview
      • 6.3.20.2. Financial performance
      • 6.3.20.3. Product benchmarking
      • 6.3.20.4. Strategic initiatives
    • 6.3.21. ST. Stone Medical Devices Private Limited
      • 6.3.21.1. Company overview
      • 6.3.21.2. Financial performance
      • 6.3.21.3. Product benchmarking
      • 6.3.21.4. Strategic initiatives
    • 6.3.22. Custom Wire Technologies, Inc.
      • 6.3.22.1. Company overview
      • 6.3.22.2. Financial performance
      • 6.3.22.3. Product benchmarking
      • 6.3.22.4. Strategic initiatives
    • 6.3.23. ACE Medical Devices
      • 6.3.23.1. Company overview
      • 6.3.23.2. Financial performance
      • 6.3.23.3. Product benchmarking
      • 6.3.23.4. Strategic initiatives
    • 6.3.24. BrosMed Medical Co., Ltd.
      • 6.3.24.1. Company overview
      • 6.3.24.2. Financial performance
      • 6.3.24.3. Product benchmarking
      • 6.3.24.4. Strategic initiatives
    • 6.3.25. Cathwide Medical Co. Ltd.
      • 6.3.25.1. Company overview
      • 6.3.25.2. Financial performance
      • 6.3.25.3. Product benchmarking
      • 6.3.25.4. Strategic initiatives
    • 6.3.26. Creo Medical
      • 6.3.26.1. Company overview
      • 6.3.26.2. Financial performance
      • 6.3.26.3. Product benchmarking
      • 6.3.26.4. Strategic initiatives
    • 6.3.27. Foshan Dihua Technology Co., Ltd.
      • 6.3.27.1. Company overview
      • 6.3.27.2. Financial performance
      • 6.3.27.3. Product benchmarking
      • 6.3.27.4. Strategic initiatives
    • 6.3.28. AngioDynamics
      • 6.3.28.1. Company overview
      • 6.3.28.2. Financial performance
      • 6.3.28.3. Product benchmarking
      • 6.3.28.4. Strategic initiatives
    • 6.3.29. Cordis (Cardinal Health)
      • 6.3.29.1. Company overview
      • 6.3.29.2. Financial performance
      • 6.3.29.3. Product benchmarking
      • 6.3.29.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 4. North America Guidewires market, by region, 2021 - 2033 (USD Million)
  • Table 5. North America Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 6. U.S. Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 7. Canada Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 8. Mexico Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 9. Europe Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 10. Europe Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 11. UK Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 12. Germany Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 13. France Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 14. Italy Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 15. Spain Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 16. Norway Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 17. Sweden Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 18. Denmark Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 19. Asia Pacific Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 20. Asia Pacific Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 21. Japan Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 22. China Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 23. India Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 24. Australia Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 25. South Korea Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 26. Thailand Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 27. Latin America Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 28. Latin America Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 29. Brazil Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 30. Argentina Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 31. Middle East & Africa Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 32. Middle East & Africa Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 33. South Africa Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 34. Saudi Arabia Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 35. UAE Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 36. Kuwait Guidewires market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Guidewires market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Guidewires market, product outlook key takeaways (USD Million)
  • Fig. 12 Guidewires market product movement analysis 2023 & 2030 (USD Million)
  • Fig. 13 Coronary guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Peripheral guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Urology guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Neurovascular guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Guidewires market: Regional key takeaways (USD Million)
  • Fig. 18 Guidewires market regional outlook, 2023 & 2030 (USD Million)
  • Fig. 19 North America Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 US Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Canada Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Mexico Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Europe Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 UK Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Germany Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 France Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Spain Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Italy Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Sweden Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Norway Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Denmark Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Asia Pacific Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 China Guidewires estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Japan Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 India Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 South Korea Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Australia Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Thailand Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Latin America Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Brazil Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Argentina Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Middle East and Africa Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 South Africa Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Saudi Arabia Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 UAE Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Kuwait Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 List of key emerging company's/product type disruptors/innovators